Lifecore Biomedical, Inc. De (LFCR) EBT Margin (2010 - 2025)

Lifecore Biomedical has reported EBT Margin for 16 years, with the latest figure at 22.19% in Q2 2025.

• On a quarterly basis, EBT Margin fell 334.0% year-over-year to 22.19% in Q2 2025; TTM through May 2025 was 32.59%, a 4001.0% decrease from a year earlier, with the FY2025 full-year figure at 30.01%, down 3743.0% from the prior year.
• EBT Margin was 22.19% for Q2 2025 at Lifecore Biomedical, up from 42.04% in the prior quarter.
• The five-year high for EBT Margin was 47.02% in Q4 2023, with the low at 118.05% in Q2 2023.
• Average EBT Margin over 5 years is 27.43%, with a median of 25.22% recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: EBT Margin slumped 10484 bps in 2023, then surged 9920 bps in 2024.
• Over 5 years, EBT Margin stood at 4.97% in 2021, then sank by 947 bps to 42.06% in 2022, then surged by 212 bps to 47.02% in 2023, then plunged by 143 bps to 20.05% in 2024, then retreated by 11 bps to 22.19% in 2025.
• The last three EBT Margin figures came in at 22.19% (Q2 2025), 42.04% (Q1 2025), and 20.05% (Q4 2024), per Business Quant data.